Sökning: (WFRF:(Salloway S.)) > Appropriate use cri...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03768naa a2200649 4500 | |
001 | oai:gup.ub.gu.se/274361 | |
003 | SwePub | |
008 | 240528s2018 | |||||||||||000 ||eng| | |
024 | 7 | a https://gup.ub.gu.se/publication/2743612 URI |
024 | 7 | a https://doi.org/10.1016/j.jalz.2018.07.2202 DOI |
040 | a (SwePub)gu | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Shaw, L. M.4 aut |
245 | 1 0 | a Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease |
264 | c 2018-10-10 | |
264 | 1 | b Wiley,c 2018 |
520 | a INTRODUCTION: The Alzheimer's Association convened a multidisciplinary workgroup to develop appropriate use criteria to guide the safe and optimal use of the lumbar puncture procedure and cerebrospinal fluid (CSF) testing for Alzheimer's disease pathology detection in the diagnostic process. METHODS: The workgroup, experienced in the ethical use of lumbar puncture and CSF analysis, developed key research questions to guide the systematic review of the evidence and developed clinical indications commonly encountered in clinical practice based on key patient groups in whom the use of lumbar puncture and CSF may be considered as part of the diagnostic process. Based on their expertise and interpretation of the evidence from systematic review, members rated each indication as appropriate or inappropriate. RESULTS: The workgroup finalized 14 indications, rating 6 appropriate and 8 inappropriate. DISCUSSION: In anticipation of the emergence of more reliable CSF analysis platforms, the manuscript offers important guidance to health-care practitioners and suggestions for implementation and future research. Copyright © 2018 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Neurovetenskaper0 (SwePub)301052 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Neurosciences0 (SwePub)301052 hsv//eng |
653 | a Alzheimer's disease pathology | |
653 | a Amyloid PET | |
653 | a AUC | |
653 | a CSF Aβ-42 | |
653 | a diagnostic utilities | |
653 | a MCI | |
653 | a Modified Delphi | |
653 | a p-tau181 | |
653 | a PICOTS (population | |
653 | a interventions | |
653 | a comparisons | |
653 | a outcomes | |
653 | a timing | |
653 | a and settings) framework | |
653 | a SCD | |
653 | a t-tau | |
653 | a LP | |
700 | 1 | a Arias, J.4 aut |
700 | 1 | a Blennow, Kaj,d 1958u Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry4 aut0 (Swepub:gu)xbleka |
700 | 1 | a Galasko, D.4 aut |
700 | 1 | a Molinuevo, J. L.4 aut |
700 | 1 | a Salloway, S.4 aut |
700 | 1 | a Schindler, S.4 aut |
700 | 1 | a Carrillo, M. C.4 aut |
700 | 1 | a Hendrix, J. A.4 aut |
700 | 1 | a Ross, A.4 aut |
700 | 1 | a Illes, J.4 aut |
700 | 1 | a Ramus, C.4 aut |
700 | 1 | a Fifer, S.4 aut |
710 | 2 | a Göteborgs universitetb Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi4 org |
773 | 0 | t Alzheimer's & dementia : the journal of the Alzheimer's Associationd : Wileyg 14:11, s. 1505-1521q 14:11<1505-1521x 1552-5279 |
773 | 0 | t Alzheimer's & Dementiad : Wileyg 14:11, s. 1505-1521q 14:11<1505-1521x 1552-5260 |
856 | 4 | u https://doi.org/10.1016/j.jalz.2018.07.220 |
856 | 4 8 | u https://gup.ub.gu.se/publication/274361 |
856 | 4 8 | u https://doi.org/10.1016/j.jalz.2018.07.220 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.